Print This Page

Articles from Johns Hopkins

Articles from Johns Hopkins

Photo shows doctoral student Donna Dang, left, and Rajini Rao, who directs the Graduate Program in Cellular and Molecular Medicine, in the lab.

Doctoral  student Donna Dang, left, is conducting cancer cell research in the lab of physiology professor Rajini Rao, director of the graduate program in cellular and molecular biology.

Ensuring Biomedical Research Remains Trustworthy and Transparent
Johns Hopkins Medicine is taking steps to ensure its biomedical research remains trustworthy and transparent. The changes include expanded education for investigators and a better system for storing and sharing primary data.
Read More
Day in the Life of a Postdoc
Three Johns Hopkins postdocs shared their career aspirations, motivation for their work and what a typical day looks like.
Student-Inspired Commemorative Garden
A school of medicine commemorative garden, was dedicated at a ceremony on May 31.
Image shows clinicians piecing together a jigsaw puzzle.
Johns Hopkins and Kaiser Permanente Expand Research Collaboration
Johns Hopkins Medicine and Kaiser Permanente recently awarded a total of $300,000 in grants to four research studies that began in April 2017 and will run through March 2018.
Moms Bring ‘Cease Fire’ Message to City Streets
The Cease Fire Peace Walk on Mother’s Day weekend went down Broadway, from North Avenue, past the Johns Hopkins Hospital, to Orleans Street. Marchers carried signs and chanted their pleas to end the epidemic of violence in Baltimore.
Honoring Our Nurses
Johns Hopkins recognizes our nurses during National Nurses Week from May 6 to May 12.
Illustration depicting visual points of contact for a patient within a health system
Service Lines Put the Patient First
This summer, Johns Hopkins Medicine will embark on one of its biggest sea changes in patient care: the creation of service lines that integrate multidisciplinary services across the Johns Hopkins enterprise in three key areas.
Image of a drop of blood holding a dollar bill
Epic Promotes Evidence-Based Blood Use, Saving $1.8 Million
Johns Hopkins Medicine is on track to save $800,000 through reduced platelet use, $716,000 through reduced red blood cell use and $296,000 through reduced plasma use for fiscal year 2017 compared with fiscal year 2014, before blood management was incorporated.
Physician standing by a map of the US
ERAS Protocols to Go Nationwide to Improve Outcomes While Saving Costs
The project will enable more than 750 hospitals to implement enhanced recovery after surgery (ERAS) protocols, which have been shown to reduce complications, decrease lengths of stay and improve the patient experience.
Craig Williams Joins Johns Hopkins HealthCare as Vice President for Health Innovations and Management Solutions
In this position, Williams is responsible for building a business unit to develop innovative products and services that improve individual and population health.
Photo of an Ebola drill in progress with mock patient on a gurney being escorted by health care workers in protective suits.
Picture This: Ebola Drill
About 100 faculty and staff members from Johns Hopkins participated in the Ebola patient drill, either by planning or carrying out the exercise.
Photo of David Lictchman performing an image-guided procedure on a model.
Interventional Radiology Bedside Service at Johns Hopkins Means Shorter Waits for Patients
Patients receive image-guided procedures sooner, with fewer trips to the radiology department.
Photo of Dean/CEO Paul Rothman
Innovation in the Classroom
Graduate education is one of the core missions of Johns Hopkins Medicine. As times change for academic medical centers, we want to keep apace of the trends in medicine.

Latest in Research

a collection of antibiotic pill capsules
One in five patients prescribed antibiotics experience side effects

A new study on hospitalized adults adds to growing evidence that antibiotics are not benign and that clinicians often fail to weigh both the risks and benefits of antibiotics before prescribing them.

Read More
An image of a T-cell
Flaws in genetic mending kit drive response to immunotherapy drug

A three-year clinical trial of patients with 12 different kinds of cancer with so-called ‘mismatch repair’ genetic defects found that half responded to a drug called pembrolizumab. The findings led the U.S. Food and Drug Administration to approve expanded use of pembrolizumab for patients, the researchers also say they found evidence that the immune responses closely aligned with mutations found in their cancers. The report is published online in the June 8 issue of the journal Science.

Read More
immunoswitch particles under a microscope
Double-duty nanoparticles lower cancer's defenses while firing up the immune system

The new nanoparticle carries two different antibodies that simultaneously switch off cancer cells’ defensive properties while switching on a robust anticancer immune response in mice, dramatically slowing the growth of mouse melanoma and colon cancer.

Read More

Featured Videos

Johns Hopkins inHealth | Precision Medicine
What is precision medicine? Precision medicine involves using more measurements and data to improve diagnosis; better tailoring treatments for patients; and using technology and analytical tools to enhance patient care. Johns Hopkins inHealth is precision medicine.
Star Wars Brings Joy to Johns Hopkins Children's Center
It was a regular Friday filled with appointments and treatments—when who came zooming into Johns Hopkins Children’s Center but R2D2, uniting allies from the Rebel Alliance and villains from the Dark Side with one common goal: to make our kids forget they were in the hospital.